The rise in the Biocon share price came after its wholly-owned unit, Biocon Pharma, received USFDA nod for Everolimus tablets ...

During a live event, Benjamin Garmezy, MD, discussed combinations regimens used for patients with renal cell carcinoma after ...

Biocon posted a net profit of Rs 659.7 crore, nearly three times higher than Rs 101.4 crore posted in the corresponding ...

Biocon stock ended 4% higher at Rs 317.60 on Friday against the previous close of Rs 305.20 on BSE. The stock touched an ...

Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus tablets for oral suspension indicated for patients with tuberous ...

In the last one year, shares of Biocon zoomed up to 17 per cent, while on a year-to-date basis it cracked over 13 per cent.

Bangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received ...